Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NRX Pharmaceuticals Inc
NRXP
Financial Services
Healthcare
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of...
ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:NRXP)
New Post
View:
Posts & Comments
Threaded Posts
(227)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Nov 18, 2024 4:15pm
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as
News; $NRXP NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial OfficerNRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer PR Newswire
...more
(227)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Aug 13, 2024 7:15pm
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Qu
BREAKING NEWS: $NRXP NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 02, 2024 10:32am
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) – Developing I
https://beyondspx.com/2024/07/31/nrx-pharmaceuticals-inc-nasdaqnrxp-developing-innovative-cns-therapies/
(227)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jul 29, 2024 3:17pm
HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP
News; $NRXP HOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP) Announce Arbitration Order Enabling HOPE Therapeutics SpinoffHOPE Therapeutics, Inc. and NRx Pharmaceuticals (Nasdaq:NRXP
...more
(227)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Mar 04, 2024 3:15pm
NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, L
BREAKING NEWS: $NRXP NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient, Last Visit in its Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionNRx Pharmaceuticals
...more
(227)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 02, 2024 2:00pm
NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance w
News; $NRXP NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS StandardNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance with Nasdaq MVLS Standard PR Newswire Company
...more
(29)
•••
flight100
X
View Profile
View Bullboard History
Post by
flight100
on May 26, 2022 1:42pm
NRXP is rebounding now 0.57
eom
(29)
•••
flight100
X
View Profile
View Bullboard History
Post by
flight100
on May 26, 2022 1:02pm
Buying NRXP at 0.5 It still has $40mil cash in its treasury
As per NRXP financial news, NRXP had $40 million cash as of March 31. So, current price 0.51 is steal and the stock price should move up very quickly. As of March 31, 2022, cash was
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 11, 2021 8:01am
NRXP ...... NR on watch
Do some research
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Oct 19, 2021 8:05am
ALL YOU NEED TO KNOW ABOUT NRX PHARMACEUTICALS!
$NRXP There is a lot of buzz around NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing ZYESAMI™ (AVIPTADIL®) for the treatment of respiratory
...more
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Oct 14, 2021 11:50pm
NRXP - Thursday Rundown, Friday Expectations
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden